e-learning
resources
London 2016
Tuesday, 06.09.2016
Exploring mechanisms in health and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does positive bronchodilator reversibility testing predict positive bronchoprovocative methacholine challenge testing in suspected asthma patients
Nataša Karamarković Lazarušić (Zagreb, Croatia), Nataša Karamarkovic Lazarušic, Bojana Butorac Petanjek, Anita Ljubicic, Melita Jeric
Source:
International Congress 2016 – Exploring mechanisms in health and disease
Session:
Exploring mechanisms in health and disease
Session type:
Poster Discussion
Number:
3441
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nataša Karamarković Lazarušić (Zagreb, Croatia), Nataša Karamarkovic Lazarušic, Bojana Butorac Petanjek, Anita Ljubicic, Melita Jeric. Does positive bronchodilator reversibility testing predict positive bronchoprovocative methacholine challenge testing in suspected asthma patients. Eur Respir J 2016; 48: Suppl. 60, 3441
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Comparison of the sensitivity and specificity of the methacholine challenge test and exercise test for the diagnosis of asthma in athletes
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge in suspected asthmatics
Source: International Congress 2018 – Asthma management
Year: 2018
Fluticasone propionate in clinically suspected asthma patients with negative methacholine challenge test
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Comparison of mannitol and methacholine challenge test for the diagnosis of asthma in athletes
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Limitations of forced spirometry in the detection of bronchodilator response in asthmatic children
Source: International Congress 2015 – Paediatric respiratory physiology
Year: 2015
Evaluating airway resistance changes by body plethysmography in methacholine challenge test
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Reliability, consistency and variability of base-line spirometric and plethysmographic measurements prior to methacholine challenge tests assess airway hyperreactivity (AHR)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Concordance between oscillometric and spirometric lung function measures in bronchodilator response test for the detection of airway obstruction
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
FEV1 and sRaw in bronchial challenge testing, exchangeable or supplementaFEV1 and sRaw in bronchial challenge testing, exchangeable or supplemental?
Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system
Year: 2015
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Predictive factors of a positive methacholine challenge response based on data from a baseline respiratory function test
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Association between sputum cytology and lung function in patients with asthma and COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Bronchodilation test estimation using spirometry and electrical impedance analysis in bronchial asthma and COPD patients
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Comparative study of bronchial provocation tests using methacholine or mannitol in bronchial asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Validity of the forced expiratory flow 25-75 for identification of bronchial hyperresponsiveness in a pulmonary function laboratory
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
Specificity and sensitivity of the methacholine challenge test for the diagnosis of asthma in athletes
Source: Annual Congress 2012 - Predicting the future: the impact of reference values on a range of respiratory paramaters
Year: 2012
Yield of a mannitol bronchial provocation test (BPT) for the diagnosis of asthma in a real-life study
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
Comparison of exercise provocation and induced sputum measurement in patients with positive methacholine provocation test
Source: Eur Respir J 2005; 26: Suppl. 49, 371s
Year: 2005
ΔFEF25-75 a surrogate marker for mild intermittent asthma: A poor man’s FeNO
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Use FEV6 and FEV1/FEV6 as alternative indicators in the diagnosis of bronchial obstruction in primary care
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept